Search Results

There are 5982 results for: content related to: Advance Market Commitments for R & D in Diseases That Disproportionately Affect Low-Income Countries

  1. Global Health Policy Responses to the World's Neglected Diseases

    The Handbook of Global Health Policy

    Garrett W. Brown, Gavin Yamey, Sarah Wamala, Pages: 229–244, 2014

    Published Online : 11 APR 2014, DOI: 10.1002/9781118509623.ch12



    Volume 23, Issue 7, September 2009, Pages: 413–420, JORN SONDERHOLM

    Article first published online : 29 JUL 2009, DOI: 10.1111/j.1467-8519.2009.01753.x

  3. Innovation Incentives under Transferable Fast-Track Regulatory Review

    The Journal of Industrial Economics

    Volume 61, Issue 3, September 2013, Pages: 789–816, Joshua S. Gans and David B. Ridley

    Article first published online : 21 OCT 2013, DOI: 10.1111/joie.12026

  4. Needs-Driven Versus Market-Driven Pharmaceutical Innovation: The Consortium for the Development of a New Medicine against Malaria in Brazil

    Developing World Bioethics

    Volume 14, Issue 2, August 2014, Pages: 101–108, Koichi Kameda

    Article first published online : 25 APR 2014, DOI: 10.1111/dewb.12056

  5. You have free access to this content
    Editorial: Drug development for neglected diseases: a public health challenge

    Tropical Medicine & International Health

    Volume 11, Issue 9, September 2006, Pages: 1335–1338, Angela Fehr, Petra Thürmann and Oliver Razum

    Article first published online : 24 AUG 2006, DOI: 10.1111/j.1365-3156.2006.01714.x

  6. Promising Trends in Access to Medicines

    Global Policy

    Volume 3, Issue 2, May 2012, Pages: 231–237, E. Richard Gold and Jean-Frédéric Morin

    Article first published online : 22 MAY 2012, DOI: 10.1111/j.1758-5899.2011.00110.x

  7. You have free access to this content
    Poster Sessions

    Tropical Medicine & International Health

    Volume 20, Issue S1, September 2015, Pages: 171–441,

    Article first published online : 2 SEP 2015, DOI: 10.1111/tmi.12574

  8. Patents and Pharmaceutical R&D: Consolidating Private–Public Partnership Approach to Global Public Health Crises

    The Journal of World Intellectual Property

    Volume 13, Issue 4, July 2010, Pages: 556–580, Chidi Oguamanam

    Article first published online : 11 MAR 2010, DOI: 10.1111/j.1747-1796.2010.00396.x

  9. Pioneering Use of the Cloud for Development of Collaborative Drug Discovery (CDD) Database

    Collaborative Computational Technologies for Biomedical Research

    Sean Ekins, Moses M. Hohman, Barry A. Bunin, Pages: 335–361, 2011

    Published Online : 3 MAY 2011, DOI: 10.1002/9781118026038.ch21

  10. Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness

    Health Economics

    Volume 16, Issue 5, May 2007, Pages: 491–511, Ernst R. Berndt, Rachel Glennerster, Michael R. Kremer, Jean Lee, Ruth Levine, Georg Weizsäcker and Heidi Williams

    Article first published online : 2 OCT 2006, DOI: 10.1002/hec.1176


    Developing World Bioethics

    Volume 12, Issue 3, December 2012, Pages: 121–134, NICOLE HASSOUN

    Article first published online : 7 FEB 2012, DOI: 10.1111/j.1471-8847.2011.00314.x

  12. You have free access to this content
    Improving Access to Medicines in Low-Income Countries: A Review of Mechanisms

    The Journal of World Intellectual Property

    Volume 18, Issue 1-2, March 2015, Pages: 1–28, Cindy Bors, Andrew Christie, Daniel Gervais and Ellen Wright Clayton

    Article first published online : 27 MAR 2015, DOI: 10.1111/jwip.12032

  13. You have free access to this content
    Drugs for neglected diseases: a failure of the market and a public health failure?

    Tropical Medicine & International Health

    Volume 6, Issue 11, November 2001, Pages: 945–951, Patrice Trouiller, Els Torreele, Piero Olliaro, Nick White, Susan Foster, Dyann Wirth and Bernard Pécoul

    Article first published online : 13 JAN 2002, DOI: 10.1046/j.1365-3156.2001.00803.x

  14. Pharmaceutical Innovation, Fair Following and the Constrained Value of TRIPS Flexibilities

    The Journal of World Intellectual Property

    Volume 14, Issue 2, March 2011, Pages: 202–228, Ebenezer K. Tetteh

    Article first published online : 4 JAN 2011, DOI: 10.1111/j.1747-1796.2010.00415.x



    Volume 36, Issue 1-2, January 2005, Pages: 182–209, Thomas W. Pogge

    Article first published online : 2 MAR 2005, DOI: 10.1111/j.1467-9973.2005.00362.x

  16. The Invention of an Investment Incentive for Pharmaceutical Innovation

    The Journal of World Intellectual Property

    Volume 15, Issue 5-6, December 2012, Pages: 305–364, Shamnad Basheer

    Article first published online : 20 DEC 2012, DOI: 10.1111/jwip.12001

  17. Prizes and Parasites: Incentive Models for Addressing Chagas Disease

    The Journal of Law, Medicine & Ethics

    Volume 37, Issue 2, Summer 2009, Pages: 292–304, Sara E. Crager and Matt Price

    Article first published online : 3 JUN 2009, DOI: 10.1111/j.1748-720X.2009.00373.x

  18. Priority Review Vouchers: An Inefficient and Dangerous Way to Promote Neglected-Disease Drug Development

    Clinical Pharmacology & Therapeutics

    Volume 85, Issue 6, June 2009, Pages: 573–575, AS Kesselheim

    Article first published online : 18 MAR 2009, DOI: 10.1038/clpt.2009.50

  19. A Framework to Link International Clinical Research to the Promotion of Justice in Global Health


    Volume 28, Issue 8, October 2014, Pages: 387–396, Bridget Pratt and Bebe Loff

    Article first published online : 20 DEC 2012, DOI: 10.1111/bioe.12009

  20. You have free access to this content
    Global health policy coordination to address neglected tropical diseases

    Tropical Medicine & International Health

    Volume 17, Issue 9, September 2012, Pages: 1053–1056, Tim K. Mackey and Bryan A. Liang

    Article first published online : 29 JUL 2012, DOI: 10.1111/j.1365-3156.2012.03049.x